HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $7.80 billion. The enterprise value is $8.61 billion.
| Market Cap | 7.80B |
| Enterprise Value | 8.61B |
Important Dates
The last earnings date was Tuesday, March 18, 2025, after market close.
| Earnings Date | Mar 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.50 million shares outstanding. The number of shares has increased by 2.15% in one year.
| Current Share Class | 86.50M |
| Shares Outstanding | 86.50M |
| Shares Change (YoY) | +2.15% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 106.46% |
| Float | 85.03M |
Valuation Ratios
The trailing PE ratio is 82.74 and the forward PE ratio is 24.74. HealthEquity's PEG ratio is 1.13.
| PE Ratio | 82.74 |
| Forward PE | 24.74 |
| PS Ratio | 6.53 |
| Forward PS | 5.93 |
| PB Ratio | 3.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 23.10 |
| P/OCF Ratio | 22.95 |
| PEG Ratio | 1.13 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.58, with an EV/FCF ratio of 25.50.
| EV / Earnings | 89.07 |
| EV / Sales | 7.18 |
| EV / EBITDA | 23.58 |
| EV / EBIT | 42.46 |
| EV / FCF | 25.50 |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.52.
| Current Ratio | 3.06 |
| Quick Ratio | 2.65 |
| Debt / Equity | 0.52 |
| Debt / EBITDA | 2.99 |
| Debt / FCF | 3.28 |
| Interest Coverage | 3.35 |
Financial Efficiency
Return on equity (ROE) is 4.66% and return on invested capital (ROIC) is 4.10%.
| Return on Equity (ROE) | 4.66% |
| Return on Assets (ROA) | 3.84% |
| Return on Invested Capital (ROIC) | 4.10% |
| Return on Capital Employed (ROCE) | 6.16% |
| Revenue Per Employee | $380,881 |
| Profits Per Employee | $30,699 |
| Employee Count | 3,150 |
| Asset Turnover | 0.36 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $19.33 million in taxes.
| Income Tax | 19.33M |
| Effective Tax Rate | 16.66% |
Stock Price Statistics
The stock price has increased by +13.24% in the last 52 weeks. The beta is 0.62, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +13.24% |
| 50-Day Moving Average | 104.20 |
| 200-Day Moving Average | 90.24 |
| Relative Strength Index (RSI) | 38.53 |
| Average Volume (20 Days) | 1,381,208 |
Short Selling Information
The latest short interest is 4.36 million, so 5.04% of the outstanding shares have been sold short.
| Short Interest | 4.36M |
| Short Previous Month | 4.40M |
| Short % of Shares Out | 5.04% |
| Short % of Float | 5.13% |
| Short Ratio (days to cover) | 6.08 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.20 billion and earned $96.70 million in profits. Earnings per share was $1.09.
| Revenue | 1.20B |
| Gross Profit | 777.26M |
| Operating Income | 202.87M |
| Pretax Income | 98.27M |
| Net Income | 96.70M |
| EBITDA | 365.32M |
| EBIT | 202.87M |
| Earnings Per Share (EPS) | $1.09 |
Balance Sheet
The company has $295.95 million in cash and $1.11 billion in debt, giving a net cash position of -$812.57 million or -$9.39 per share.
| Cash & Cash Equivalents | 295.95M |
| Total Debt | 1.11B |
| Net Cash | -812.57M |
| Net Cash Per Share | -$9.39 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 24.44 |
| Working Capital | 321.43M |
Cash Flow
In the last 12 months, operating cash flow was $339.86 million and capital expenditures -$2.08 million, giving a free cash flow of $337.77 million.
| Operating Cash Flow | 339.86M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | 337.77M |
| FCF Per Share | $3.91 |
Margins
Gross margin is 64.78%, with operating and profit margins of 16.91% and 8.06%.
| Gross Margin | 64.78% |
| Operating Margin | 16.91% |
| Pretax Margin | 9.67% |
| Profit Margin | 8.06% |
| EBITDA Margin | 30.45% |
| EBIT Margin | 16.91% |
| FCF Margin | 28.15% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.15% |
| Shareholder Yield | -2.15% |
| Earnings Yield | 1.24% |
| FCF Yield | 4.33% |
Analyst Forecast
The average price target for HealthEquity is $113.31, which is 25.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $113.31 |
| Price Target Difference | 25.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.05 |
| Piotroski F-Score | 6 |